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Purpose of this Paper
On May 3, 2005, the Robert Wood Johnson Foundation (RWJF) convened a Capstone 
Conference for its Addressing Tobacco in Managed Care (ATMC) national program. 
Subtitled “Synthesizing Lessons Learned and Identifying Future Research Opportunities,” 
the conference provided a forum for the discussion of the results of ATMC and the use 
of these results to build a vision for future work to reduce the prevalence of tobacco use. 
The conference was co-funded by RWJF, the Centers for Disease Control and Prevention 
(CDC), and the Agency for Healthcare Research and Quality (AHRQ). It was facilitated 
by Michael Fiore, M.D., M.P.H., and Susan Curry, Ph.D., ATMC national program 
directors at the University of Wisconsin Medical School and the University of Illinois at 
Chicago, respectively.
The purpose of this paper is to report the key points that were discussed at this conference. 
The paper will describe changes in policy and in health care systems that have proven 
effective in reducing tobacco use, it will highlight the strategies and tactics that have 
proven successful in bringing these changes about, and it will discuss how the experience 
of eight years of ATMC can inform future work to sustain and spread the gains achieved—
both to the field of tobacco use cessation and, potentially, to the management of other 
behavioral risk factors (e.g., physical inactivity, diet, risky drinking, obesity) associated with 
chronic conditions and diseases.
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The conference started with an overview by C. Tracy Orleans, Ph.D., RWJF senior scientist, 
of the aims and accomplishments of the ATMC program. Orleans explained that RWJF 
launched its ATMC program in 1997 to capitalize on developments in the health care 
delivery system that presented an exceptional opportunity to promote the integration 
of effective smoking cessation interventions into basic health care. These developments 
included the Agency for Health Care Policy and Research’s (AHCPR) 1996 clinical 
practice guideline on smoking cessation; the National Committee on Quality Assurance’s 
(NCQA’s) inclusion of a tobacco-related measure in its core HEDIS measures of health 
plan quality (to both of which RWJF contributed); and the growth of managed care itself, 
with its concomitant emphasis on preventive care, centralized systems of care and feedback 
of data on performance to providers. 
In 2000, the U.S. Public Health Service (USPHS) concluded, in its Clinical Practice 
Guideline, Treating Tobacco Use and Dependence, that systems-level strategies adopted by 
health plans, providers and practices have the potential to significantly affect tobacco use 
by patients. RWJF’s ATMC program complemented and expanded upon this conclusion 
by providing grants to evaluate the effectiveness of replicable systems-level strategies that 
would lead health care providers, practices and plans to adopt and adhere to AHCPR 
and USPHS recommendations.
The systems–level strategies identified by the USPHS guideline included 
recommendations to:
Implement tobacco-user identification systems in every clinic.
Provide education, resources and feedback to promote provider intervention.
Dedicate staff to provide tobacco dependence treatment and assess the delivery of this 
treatment in staff performance evaluations.
Promote hospital policies that support and provide inpatient tobacco dependence services.
Include tobacco dependence treatments (both counseling and pharmacotherapy) 
identified as effective in the USPHS guideline—as paid or covered services for all 
subscribers or members of health insurance packages.
Reimburse clinicians and specialists for delivery of effective tobacco dependence 
treatments—and include these interventions among the defined duties of clinicians.
The ATMC research projects examined the impact of these organizational strategies on 
such outcomes as smoker identification, tobacco use reduction among patients, rates of 
clinician intervention and costs of intervention efforts, across a full spectrum of managed 
care organization models.1
1  Results from ATMC have been published in two special supplements of the journal Nicotine and Tobacco 
Research, the first in 2002 (Volume 4 Supplement 1) and the second in April, 2005 (Volume 7 Supplement 1).
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Setting the stage for the panel discussions that followed, Orleans summarized the many 
measurable gains in how tobacco use cessation interventions are supported and used in the 
health care system since the inception of ATMC:
62 percent of smokers now report being advised by their physicians to quit, versus 40 to 
50 percent in the mid-1990s.
40 state Medicaid programs cover tobacco cessation treatment (versus 24 in the mid-1990s).
Medicare now covers smoking cessation treatment.
97.5 percent of members of America’s Health Insurance Plans (AHIP) provide full 
coverage for evidence-based tobacco cessation treatment (versus 75 percent in 1997).
There is a national portal for smoking cessation quitlines serving smokers in all 50 states 
and the District of Columbia. 
HEDIS contains three tobacco-related measures (up from one).
A search of medical research journals shows 83 citations for articles on tobacco cessation 
in managed care from 1996–2005, versus five such citations for 1980–1995.
In addition to these measurable gains, ATMC has created a field of research and a 
network of researchers who have experience changing the systems through which health 
providers treat chronic conditions, and who can evaluate, in real-world practice settings, 
the effectiveness of these systems changes. Several speakers at the Capstone Conference 
noted the contribution of the ATMC national program directors and staff in creating this 
field and research methodology, and in designing the ATMC’s work so that the program’s 
components would complement each other and form a comprehensive strategy that was 
indeed effective in achieving the results described above.
■
■
■
■
■
■
■
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The heart of the May 3, 2005 Capstone Conference began with a set of panel discussions 
(chaired by Curry and Fiore) around three categories of systems-level strategies: (1) provider 
education, reminder systems and feedback; (2) incentives and reimbursement; and (3) the 
use of technology. Each discussion included presentations from ATMC participants on 
their work in each category, as well as a review of the evidence base for the effectiveness 
of each strategy (many of the studies cited in the evidence reviews were by ATMC 
participants). Through the discussions of changes that have been evaluated, three key 
themes emerged:
Tools to support tobacco use cessation do exist and are becoming widespread, but the 
motivation (of providers and patients) to use these tools continues to be essential for 
their success. 
There is a body of knowledge beginning to be built around tools that work to build this 
motivation to change, but more research is needed in several areas. 
An important area for future study is how new treatment and delivery approaches 
(especially those based on technology) can enhance motivation to change (for both 
providers delivering advice and assistance to quit and for patients receiving it).
Provider education, reminder systems and feedback
Ronald M. Davis, M.D., F.A.C.P.M., of the Henry Ford Health System presented a review 
of the evidence from two sources: 
The Task Force on Community Preventive Services (American Journal of Preventive 
Medicine, 20(2S): 16–66, 2001).
The Cochrane Collaboration (Jamtvedt G, Young JM, Kristoffersen DT, Thomson 
O’Brien MA, Oxman AD. “Audit and Feedback: Effects on Professional Practice and 
Health Care Outcomes.” Cochrane Database System Review. (3): CD000259, 2003). 
The evidence shows that the most effective strategies are those that affect system operations: 
provider reminder systems, for example, do work, while insufficient evidence exists that 
provider education interventions alone are effective. This is not a provider-only issue; 
interventions that support the provider’s actions are required. Examples of such systems-
related interventions include a combination of provider education and feedback (strong 
evidence exists to support such an intervention), as well as interventions that include patient 
education. There is some evidence that audit and feedback can be effective in improving 
professional practice in general, although the effects may be small to moderate. 
1.
2.
3.
■
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The experience of participants in the ATMC program confirmed these findings. Charles 
Bentz, M.D., F.A.C.P., of Providence Health System and William Wadland, M.D., M.S., of 
Michigan State University College of Human Medicine each described a doubling of rates 
of providers advising their smoking patients to quit after interventions that included some 
combination of provider reminders, education and feedback on results. 
Bentz and Wadland were joined in the discussion by Sue Swartz, M.D., M.P.H., of 
the Maine Medical Center whose ATMC project found that interventions involving 
provider education and feedback require strong social support to be effective; intensive 
face-to-face work with providers is one way of giving this support. Other Capstone 
Conference participants highlighted the importance of developing interventions that 
match the specifics of the practice’s organization. Provider education, reminder systems 
and feedback, for example, may be easier to implement in staff model managed care 
organizations with their centralized organizational structures, medical records and 
information systems. Having a clinical champion within a practice can also increase the 
chance of such interventions being successful. 
Incentives and reimbursement
Evidence for the effectiveness of strategies involving patient co-pays, incentives and 
provider reimbursement was summarized by Helen Halpin, Ph.D., of the University 
of California at Berkeley School of Public Health, who described results for incentives 
directed at smokers themselves and at health care providers. “The Guide to Community 
Preventive Services: Tobacco Use Prevention and Control: Reviews, Recommendations 
and Expert Commentaries,” in the American Journal of Preventive Medicine2 recommends 
reducing smokers’ out-of-pocket treatment costs based on evidence that co-pay reductions 
increase treatment use and long-term quit rates. Halpin noted that the 2005 Cochrane 
Collaboration (Kaper J, Wagena EJ, Severens JL, Van Schayck CP. “Healthcare Financing 
Systems for Increasing the Use of Tobacco Dependence Treatment”3) found stronger 
evidence for patient co-pay elimination than co-pay reduction, based on several new 
studies, including two funded under the program (Roski J, Jeddeloh R, An L, Lando H, 
Hannan P, Hall C, Zhu SH. “The Impact of Financial Incentives and a Patient Registry 
on Preventive Care Quality: Increasing Provider Adherence to Evidence-Based Smoking 
Cessation Practice Guidelines” in Preventive Medicine;4 and Boyle RG, Solberg L, Magnan 
S, Davidson G, Alesci NL. “Trends: Does Insurance Coverage for Drug Therapy Affect 
Smoking Cessation?” in Health Affairs5).
2  American Journal of Preventive Medicine, 20(2) Supplement, 2001.
3  Cochrane Database System Review, (1): CD004305, January 25, 2005.
4  Preventive Medicine, 36(3): 291–9, 2003
5  Health Affairs, 21(6): 162–8, 2002
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For providers, the evidence shows that certain types of rewards—particularly those that take 
place at the system level—do make a difference in getting providers to support tobacco 
use cessation. These incentives or rewards include extra income or public recognition 
for providing high-quality care as well as incentives created by accreditation measures 
from national organizations, such as the NCQA’s HEDIS measures. For example, health 
plans reporting higher scores on their tobacco-related HEDIS measures may be publicly 
recognized as providing higher quality care. 
The presenters from ATMC sites highlighted several relevant findings from their work on 
incentives. Financial incentives can be costly and may be difficult to sustain over time. 
Joachim Roski, Ph.D., M.P.H., reported on a project at Allina Medical Group that studied 
the impact of a $5,000 incentive to clinics and found a modest impact from the incentive 
on clinician behavior. Moreover, incentives must be noticeable: the Massachusetts 
General Hospital study, described by Nancy Rigotti, M.D., showed that direct payment 
to physicians had a positive impact but a modest salary incentive, paid annually, did not. 
This study also showed that the changed behavior lasted only as long as the incentive did. 
Finally, in discussing the expected impact of the growing interest in “pay for performance” 
efforts, participants highlighted the problem that the reliance of most financial incentive 
programs on administrative data alone—which may not capture all smoking cessation 
interventions—will limit the usefulness of pay for performance efforts regarding smoking 
cessation strategies. 
Technology 
Victor Strecher, Ph.D., M.P.H., of the University of Michigan presented a framework for 
evaluating technology used to disseminate tobacco cessation information. Highlighting 
the potential of e-technology, Strecher noted that over seven million individuals use the 
Internet to search for information on smoking cessation. The Internet also is a low-cost 
option and can be used to individually tailor intervention components. More research 
is required to understand the optimal design of a tailored message as well as how other 
technologies (e.g., electronic medical records) can be integrated into the tailoring process. 
David Albert, D.D.S., M.P.H., and Anna McDaniel, D.N.S., R.N., reported on experience 
within ATMC with interventions involving new technologies. Albert and his colleagues 
at Columbia University School of Dental and Oral Surgery found that technology-based 
provider coaching, using CD-ROMs and e-mail, can be an effective tool to increase 
dentists’ use of the USPHS clinical practice guidelines. Study results showed an increase 
in dentist screening for tobacco use among their patients. While the study did not result 
in an increase in patients’ quitting smoking, it did show reduction in tobacco use among 
the patients counseled. McDaniel, of Indiana University, reported on the use of interactive 
voice technology to collect patient data that were then uploaded into an electronic medical 
record and used to generate reminders for providers to address tobacco use during routine 
clinical visits.
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The evaluation studies of ATMC provide a great deal of information about health systems 
strategies to encourage tobacco use cessation. The studies have shown strategies that 
work and strategies that don’t work, and—equally valuable—have clarified areas for future 
research. Each of the three capstone panel discussions identified a research agenda in its 
topic area:
A better understanding of what constitutes optimal provider feedback is needed to learn 
the best metrics on which to give feedback, how often it should be delivered, and how 
best to assess the impact of feedback on clinical practice. Future research opportunities 
include evaluating what feedback should focus on, how often feedback should be 
delivered, and how best to get and use outcome information as part of this feedback to 
increase the feedback’s effectiveness.
A better understanding of the impact of incentives is also important. Still unanswered 
are questions regarding the optimal size of financial incentives that have an impact on 
providers, and alternative targets for improvement beyond “advice rates,” which are 
often used. As the federal Centers for Medicare & Medicaid Services and other payors 
move to payment for services based on quality indicators, the answers to these questions 
become critical.
A greater understanding of the correct mix of technologies is needed. What is the right 
combination of technological support and face-to-face contact? Is it possible that finely 
tailored cessation materials will limit patient choices? Does the usefulness of technology 
vary among ethnic, racial or socio-economic groups? What are effective methods of 
promoting and recruiting participants to use tools such as interactive Web sites? For 
these tools, the costs of promotion could be higher than the costs of the content, an 
inversion of the usual relationship between the two. 
The presentations and discussions at the Capstone Conference highlighted the need to 
design messages about smoking cessation that will motivate providers and patients to use 
existing tools to realize change. A key ATMC finding is that tailoring and customization 
make all strategies more effective, and to RWJF’s James Marks, M.D., M.P.H., senior vice 
president and director of the Health Group, this concept of “message relevance” becomes 
in itself a new form of incentive. Specifically, the findings of ATMC’s studies showed the 
importance of adapting feedback mechanisms to practices’ organizational characteristics, as 
well as the value of personalizing feedback to the provider. Technology greatly increases the 
ability to tailor messages to their recipients and to deliver these tailored messages to people 
in a wide range of settings—at many places in the health care delivery system—quickly and 
cheaply. Tailoring is a field of inquiry with tremendous potential, and further evaluation is 
warranted to determine when and how tailoring can have the greatest impact.
Ultimately, the research that will help design effective motivating messages must take place 
in real practice settings. ATMC provides a model for this by evaluating the effectiveness of 
systems changes in a variety of models of managed care plans. 
■
■
■
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ATMC has developed a body of knowledge about effective health system innovations to 
ensure delivery of evidence-based smoking cessation interventions and has informed a 
research agenda for the future. Many of the questions and interests that arose out of ATMC 
were echoed in the future directions laid out at the capstone conference by governmental 
and private sector policy-makers and funders.
Carolyn Clancy, director of AHRQ, described the importance to the agency’s mission 
of actions that spur system change and create tools so that system change can occur. She 
announced AHRQ’s intention of reforming a consortium to update the tobacco cessation 
clinical practice guidelines, with special focus on areas in which new research has become 
available since the guidelines were last revised in 2000—including youth cessation, quitlines, 
special populations, pharmacotherapy, people with psychiatric conditions and making 
the business case for cessation. Clancy also reported that AHRQ had just released Helping 
Smokers Quit, a Guide for Nurses. The guide, prepared in partnership with Tobacco-Free 
Nurses: Helping Nurses Quit, a program funded by RWJF in August 2003, is working to 
assist the nation’s nearly three million practicing nurses in helping their patients—and 
themselves, if they are smokers—quit using tobacco. In terms of needed research, Clancy 
highlighted the prevalence of racial, ethnic and socioeconomic disparities in tobacco use, 
and the effects of tobacco on women and girls, and stressed the importance of linking 
research studies to real-world practice settings. Clancy praised the network of researchers 
built by ATMC and called for more of such networks, noting their power to influence 
policy, and pledged her commitment to continued collaboration with such work.
Other speakers from a range of both public and private funding agencies described their 
organizations’ interests and offered suggestions as to how their areas of focus might 
intersect with the future research needs identified through ATMC. 
Mark Clanton, M.D., M.P.H., of the National Cancer Institute (NCI) highlighted the 
NCI’s interest in funding research into the effectiveness of systems change and noted 
several specific programs underway, especially the NCI’s seven Transdisciplinary Tobacco 
Use Research Centers (TTURCS), funded at $12 million over five years (with support 
from RWJF). The TTURCs work across disciplines to gain better understanding of 
the etiology of tobacco use and addiction, the impact of advertising and marketing on 
tobacco use, effective prevention strategies, the treatment of tobacco use and addiction, 
the identification of biomarkers and the impact of tobacco exposure. 
The American Legacy Foundation focuses its work on identifying new and better ways 
to provide smoking cessation programs for smokers who want to quit, with a special 
emphasis on culturally tailored cessation strategies. Cheryl Healton, Dr.P.H., Legacy’s 
president and CEO, said that a key lesson learned from throughout Legacy’s work is 
that “if you market it, they will come.” She confirmed Strecher’s observation that the 
tailoring of messages is critical to their success, and added that Legacy will be building 
its Web site into an active tool to support smoking cessation. 
■
■
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The CDC funds both research and programs directed to tobacco use cessation. A major 
area of current focus, reported Ann Malarcher, Ph.D., M.S.P.H., of the CDC’s Office 
on Smoking and Health, is its newly-released report on key outcome indicators for 
evaluating comprehensive tobacco control programs. The report identifies a number of 
short-term outcomes, but Malarcher noted that the CDC has not yet achieved consensus 
on a set of indicators to measure each outcome, highlighting this as an area where future 
research would be most helpful.
RWJF has provided a two-year, $400,000 grant to the ATMC’s national program office 
for a “roots and wings” strategy to help sustain the network of researchers created by 
ATMC and to further its impact. The goal, explained Orleans of RWJF, is to help 
ATMC’s work get “into the DNA of ongoing health care quality improvement.” 
RWJF also will be integrating its work on tobacco, and its ATMC-gained experience 
in developing practice-based research networks, into a broad focus on multiple risk 
factors for chronic illness, including tobacco use as one of four risk factors (lack of 
physical activity, unhealthy diet, tobacco use, risky use of alcohol) that will be the 
subject of intervention efforts. This program, Prescription for Health, is a joint effort of 
RWJF, AHRQ and the Office of Behavioral and Social Science Research (OBSSR) at the 
National Institutes of Health (NIH). RWJF’s established Substance Abuse Policy Research 
Program will provide ongoing funding for tobacco-related health care system change 
research similar to that supported under ATMC.
Gaining a better understanding of the barriers to widespread use of smoking cessation 
tools is a strong interest of the National Institute on Drug Abuse (NIDA). Beverly 
Pringle, Ph.D., of NIDA described a research agenda that will look at such issues as the 
high percentage of substance users who are also addicted to tobacco, the need for more 
effective tobacco use prevention interventions in elementary and secondary schools, 
and the lack of understanding in the primary care setting of the nature of all types of 
addiction, including addiction to tobacco.
Complementing Carolyn Clancy’s comments, Tricia Trinité, M.S.P.H., A.P.R.N., of 
AHRQ’s Center for Primary Care, Prevention and Clinical Partnerships, highlighted 
AHRQ’s interest in linking clinical interventions around tobacco use cessation with 
interventions that are in the community. Some funding is available for provider-initiated 
projects to explore what types of interventions are suited to which venue, and how best 
to coordinate the two.
■
■
■
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The ATMC Capstone Conference demonstrated ATMC’s accomplishments in identifying, 
implementing and evaluating changes in the systems of care that increase the use of 
evidence-based tobacco use cessation strategies and, through these strategies, decrease the 
numbers of people who use tobacco.
The conference provided additional evidence of ATMC’s accomplishments. The best 
research raises more questions, as emerging findings lead to new ideas about how best to 
address the topic of study. The discussion at the Capstone Conference included many new 
questions about how the system changes tested in ATMC could be made to work even 
more effectively. 
A key area for future exploration appears to be how best to build demand among providers 
and patients for the tobacco-use cessation tools tested through ATMC and other such 
efforts. From the discussion at the Capstone Conference, a hypothesis emerged that the 
use of technology to target outreach and information tools, combined with feedback to 
providers on their use, may increase motivation to change. 
While there are relatively few organizations able to fund the next round of research (and 
these potential funders have limited funds), there is wide recognition that ATMC-like 
changes to systems of care are required and that these are the types of changes that should 
be supported. The funders also are, as a group, interested in exploring reduction in tobacco 
use as part of a broader focus on behavioral approaches to the prevention and management 
of chronic disease.
Ultimately, the most engaging prospect raised by ATMC is whether the system-based 
interventions developed under its auspices can be translated, as one participant said, “from 
one system to another.” ATMC provided a model of practice-based research; the challenge 
for the model is to apply it further, and see how far its effectiveness can reach. 
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